Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease
dc.authorid | KAYA, Emin/0000-0001-8605-8497 | |
dc.authorwosid | KAYA, Emin/W-2951-2017 | |
dc.contributor.author | Karincaoglu, Y | |
dc.contributor.author | Kaya, E | |
dc.contributor.author | Esrefoglu, M | |
dc.contributor.author | Aydogdu, I | |
dc.date.accessioned | 2024-08-04T20:13:36Z | |
dc.date.available | 2024-08-04T20:13:36Z | |
dc.date.issued | 2003 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Chronic myeloid leukemia (CML) is a myeloproliferative disease arising from abnormal stem cells and associated with splenomegaly and leukocytosis. Hydroxyurea and interferon alpha are used in treatment very frequently. Behcet's disease (BD) is a chronic, repetitive disease of unknown etiology and associated with mucocutaneous, ocular, vascular and central nervous system involvement. Cases with symptoms of BD have been reported during interferon alpha treatment of CML. However, similar symptoms due to hydroxyurea treatment have been reported in only one case until now. A 32-year-old female patient under follow up because of CML and BD, developed a large genital ulcer during hydroxyurea treatment. Ulcers due to hydroxyurea treatment and the co-existence of these two diseases has been reported in only one case in the literature while large genital ulcers have not been reported previously. | en_US |
dc.identifier.doi | 10.1080/1042819031000067864 | |
dc.identifier.endpage | 1065 | en_US |
dc.identifier.issn | 1042-8194 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 12854911 | en_US |
dc.identifier.scopus | 2-s2.0-0346461015 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 1063 | en_US |
dc.identifier.uri | https://doi.org/10.1080/1042819031000067864 | |
dc.identifier.uri | https://hdl.handle.net/11616/93704 | |
dc.identifier.volume | 44 | en_US |
dc.identifier.wos | WOS:000181514800026 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Leukemia & Lymphoma | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Behcet's syndrome | en_US |
dc.subject | leukemia | en_US |
dc.subject | chronic myeloid leukemia | en_US |
dc.subject | hydroxyurea | en_US |
dc.subject | ulcer | en_US |
dc.title | Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease | en_US |
dc.type | Article | en_US |